Related Experiment Video

Updated: Jun 6, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Vitamin K2-derived compounds induce growth inhibition in radioresistant cancer cells

Helfi Amalia1, Ryohei Sasaki, Yoko Suzuki

  • 1Divisions of Radiation Oncology, Kobe University Graduate School of Medicine, 7-5-2 Kusunokicho Chuouku Kobe City, Hyogo 650-0017, Japan.

The Kobe Journal of Medical Sciences
|November 11, 2010
PubMed

Insights

Newly developed vitamin K2 (VK2) derivatives, MQ-1, MQ-2, and MQ-3, show potent anti-cancer effects against various cancer types, including radioresistant cells. These compounds combat cancer by generating reactive oxygen species (ROS).

Area of Science:

  • Oncology
  • Cancer Biology
  • Radiotherapy Research

Background:

  • Developing strategies to overcome radioresistance in cancer treatment is crucial.
  • Appropriate experimental models are essential for evaluating novel anti-cancer therapies.
  • Radioresistant cancer models are needed to test new therapeutic agents effectively.

Purpose of the Study:

  • To establish and characterize radioresistant tumor models from human colon cancer cells.
  • To evaluate the anti-cancer and radio-sensitizing effects of novel vitamin K2 (VK2) derivatives.
  • To investigate the molecular mechanisms underlying the efficacy of these VK2 derivatives, including reactive oxygen species (ROS) generation.

Main Methods:

  • Established radioresistant tumor models from HCT116 human colon cancer cell line using fractionated radiation exposure and single-cell cloning.
  • Synthesized novel VK2 derivatives (MQ-1, MQ-2, MQ-3).
  • Assessed growth inhibitory effects on various cancer cell lines (colon, lung, breast) and radioresistant cells.
  • Evaluated ROS generation using flow cytometry and radio-sensitivity using colony-forming assays.

Main Results:

  • The established radioresistant HCT116 cells exhibited resistance to radiation and cisplatin, with high NF-κB activation.
  • The novel VK2 derivatives (MQ-1, MQ-2, MQ-3) demonstrated significant growth inhibitory effects on both conventional and radioresistant cancer cells.
  • The anti-cancer efficacy of these compounds was attributed to their ability to induce ROS generation.

Conclusions:

  • A novel radioresistant colon cancer model, characterized by NF-κB activation, was successfully established and validated as a tool for anti-tumor agent evaluation.
  • The synthesized VK2 derivatives (MQ-1, MQ-2, MQ-3) show promise as potential anti-cancer agents for various cancers, including radioresistant and recurrent types.
  • The ROS-generating capacity of these VK2 derivatives is key to their anti-tumor activity, suggesting a new therapeutic avenue for challenging cancers.

More Related Videos

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...